FDA NDC Directory · JSON-LD · Markdown

oxaliplatin

NDC 25021-233 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerSagent Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA203869
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsOXALIPLATIN (5 mg/mL)
Marketing started20140915
Package count2

External sources

Source: openFDA. Public-domain (CC0).